Brett Brown's lifelong passion for reading, driven by a quest for knowledge, naturally gave rise to his interest in biology and its many topics. As an undergraduate, he realized that research could not only expand our scientific understanding but is also critical to helping those affected by disease. His interest in translational research led him to pursue graduate studies at St. Jude Children’s Research Hospital, which he believes will allow him to eventually make meaningful scientific contributions with clinical relevance.
Brown graduated summa cum laude from the University at Albany, State University of New York, with a B.S. in biology. During the summer of his sophomore year, he interned at Regeneron Pharmaceuticals in the division responsible for the production of large-scale therapeutics, including their monoclonal antibody for COVID-19. He conducted undergraduate research under the mentorship of Dr. Jonathan Harton at Albany Medical College, where he explored the role of NLRP3 inflammasome genetics in infectious disease outcomes. After graduating, he joined as a research technician, continuing to study the NLRP3 inflammasome and its associated regulator, Pyrin-Only Protein 2 (POP2), in the context of inflammatory disorders.
Hometown: Orchard Park, New York